These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 2571139)

  • 1. Neuropeptide Y-induced pressor responses: activation of a non-adrenergic mechanism, potentiation by reserpine and blockade by nifedipine.
    Mabe Y; Tatemoto K; Huidobro-Toro JP
    Eur J Pharmacol; 1985 Oct; 116(1-2):33-9. PubMed ID: 2414116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical sympathectomy reveals pre- and postsynaptic effects of neuropeptide Y (NPY) in the cardiovascular system.
    Mabe Y; Pérez R; Tatemoto K; Huidobro-Toro JP
    Experientia; 1987 Sep; 43(9):1018-20. PubMed ID: 3115818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic pressor action of neuropeptide Y and norepinephrine in conscious rats.
    Itoi K; Mouri T; Takahashi K; Sasaki S; Imai Y; Yoshinaga K
    J Hypertens Suppl; 1986 Dec; 4(6):S247-50. PubMed ID: 3475412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats.
    Zukowska-Grojec Z; Haass M; Bayorh MA
    Regul Pept; 1986 Sep; 15(2):99-110. PubMed ID: 3786837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide tyrosine (NPY)-induced potentiation of the pressor activity of catecholamines in conscious rats.
    López LF; Pérez A; St-Pierre S; Huidobro-Toro JP
    Peptides; 1989; 10(3):551-8. PubMed ID: 2571139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.